Research Applications of Ibutamoren MK-677
Ibutamoren (MK-677) is a non-peptide growth hormone secretagogue that has advanced through Phase II clinical studies for growth hormone deficiency and sarcopenia applications. As an oral ghrelin receptor agonist, this compound demonstrates unique bioavailability characteristics compared to peptide-based research chemicals. Investigators at Stroid UK Shop examine its mechanisms in metabolic research protocols, particularly focusing on its ability to stimulate pulsatile GH release without affecting cortisol levels in preclinical models.
Molecular Mechanisms and Research Protocols
Research into MK-677 demonstrates its selective activity at ghrelin receptors, distinguishing it from traditional SARMs through its growth hormone axis modulation. Laboratory studies investigate how this compound influences energy homeostasis pathways and metabolic regulation mechanisms. The oral bioavailability profile makes it particularly valuable for research requiring consistent dosing schedules in animal models. Studies examining its effects on IGF-1 levels and sleep architecture patterns provide insights into growth hormone signalling pathways. Researchers often compare its activity profiles with peptide-based compounds to understand receptor selectivity mechanisms.
Technical Specifications
| Chemical Name | 2-amino-2-methyl-N-[(1R)-1-(1H-indol-3-ylmethyl)-1-[[(1S)-1-methylsulfonylethyl]carbamoyl]ethyl]propanamide |
|---|---|
| CAS Number | 159634-47-6 |
| Molecular Formula | C₂₇H₃₆N₄O₅S |
| Molecular Weight | 528.66 g/mol |
| Storage Conditions | Room temperature, dry environment |
| Manufacturer | Nakon Medical |
Researchers studying this compound within the Ibutamoren category analyse its stability profiles and receptor binding kinetics for comprehensive research applications.
Research Compliance and Laboratory Use
This product is manufactured by Nakon Medical exclusively for in-vitro research purposes and is not intended for human consumption, therapeutic use, or any application outside controlled laboratory environments. Research institutions must ensure proper handling protocols and compliance with relevant research guidelines when investigating this compound’s properties and mechanisms of action.
